Yangyin Huowei mixture alleviates chronic atrophic gastritis by inhibiting the IL-10/JAK1/STAT3 pathway

Table 2 Effects of Yangyin Huowei mixture on serum PG and G-17 levels in rats (mean ± SD)

Group	n	PG-I (ng/mL)	PG-II (ng/mL)	PGR	G-17 (pg/mL)
Blank control	6	82.41 ± 3.53d,e	23.06 ± 0.96d,e	3.74 ± 0.17	493.09 ± 12.17d,e
Model	6	38.52 ± 1.71c,e	11.06 ± 0.70c,e	3.72 ± 0.29	225.52 ± 17.44c,e
Low-dose YYHWM	6	71.98 ± 4.26c,d,e	18.44 ± 1.01c,d,e	3.91 ± 0.28b	433.82 ± 20.18c,d,e
Medium-dose YYHWM	6	61.64 ± 3.18c,d,e	16.94 ± 1.19c,d,e	3.65 ± 0.30	375.25 ± 30.03c,d,e
High-dose YYHWM	6	50.41 ± 3.53b,c,d	15.33 ± 1.24b,c,d	3.30 ± 0.29a	329.22 ± 29.11b,c,d
Vitacoenzyme	6	45.52 ± 5.71c,d	13.06 ± 1.10c,d	3.51 ± 0.57	283.53 ± 22.66c,d
F value		115.63	99.35	2.525	111.46
P value		< 0.01	< 0.01	0.051	< 0.01

^aP < 0.05 compared with blank control group.

^bP < 0.05 compared with model group.

^cP < 0.01 compared with blank control group.

^dP < 0.01 compared with model group.

^eP < 0.01 compared with vitacoenzyme group.

YYHWM: Yangyin Huowei mixture.